×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| Vineet Laboratories Limited | 181.32 | -57.07 | 180.99 | -6.19 | 39.4 | |
| MEDINOVA DIAGNOSTIC SERVICES L | 22.80 | 3.81 | 22.51 | 0.38 | 36.8 | 40.5 |
| Concord Drugs Limited | 118.51 | 0.54 | 118.41 | 0.05 | 34.6 |
Vineet Laboratories Limited, with Security Code 543298, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 39.5 | 66.7 | 57.2 | 37.5 | 43.3 | 32.6 | 37.0 | 23.8 | 18.9 | 18.0 |
| Expenses | 43.5 | 64.8 | 51.4 | 37.3 | 39.2 | 33.3 | 33.6 | 24.7 | 19.3 | 22.2 |
| Operating Profit | -4.0 | 2.0 | 5.8 | 0.3 | 4.2 | -0.6 | 3.4 | -0.8 | -0.3 | -4.1 |
| OPM % | -10.15% | 2.92% | 10.15% | 0.69% | 9.61% | -1.96% | 9.22% | -3.33% | -1.61% | -22.86% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.4 | 0.2 | 0.0 |
| Interest | 0.6 | 1.0 | 0.4 | 1.0 | 1.0 | 1.1 | 1.7 | 1.1 | 1.0 | 1.0 |
| Depreciation | 0.7 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 |
| Profit before tax | -5.3 | 0.4 | 4.9 | -1.3 | 2.5 | -2.3 | 1.4 | -2.2 | -1.7 | -5.7 |
| Tax % | -11.8% | 235.7% | 26.9% | -2.5% | 4.9% | -11.4% | 34.2% | -1.7% | -6.8% | -0.6% |
| Net Profit | -4.7 | 1.4 | 3.5 | -1.3 | 2.4 | -2.1 | 1.9 | -2.1 | -1.8 | -5.7 |
| EPS in Rs | -5.1 | 1.51 | 3.85 | -1.36 | 2.62 | -2.24 | 2.09 | -2.31 | -1.98 | -6.19 |
| Metrics |
|---|
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit |
| EPS in Rs |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -15% |
| TTM: | -43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -24% |
| TTM: | -392% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -12% |
| 1 Year: | -30% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|